ALLENA PHARMACEUTICALS INC (ALNA)

US0181191075 - Common Stock

0.075  +0 (+3.16%)

After market: 0.0665 -0.01 (-11.33%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2022-6-30)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
2018
(2018-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
41.03M47.65M31.99M46.92M35.59M
Research and Development
28.77M34.97M20.38M37.24M26.38M
Selling, General, and Administrative Expenses
12.26M12.68M11.60M9.68M9.22M
Operating Income
-41.03M-47.65M-31.99M-46.92M-35.59M
Interest Income/Expense
-855.00K-976.00K-510.00K270.00K580.00K
Other Income/Expense
-1.42M-38.00K-350.00K-80.00K-10.00K
Non Recurring Items
N/A0.000.00-610.00K-620.00K
Income Before Taxes
-43.30M-48.66M-32.85M-47.34M-35.65M
Income Tax
N/AN/AN/AN/AN/A
Net Income
-43.30M-48.66M-32.85M-47.34M-35.65M
EBITDA
-40.57M-47.29M-31.82M-46.76M-35.51M
 
Per Share Data
EPS Diluted Total Ops
-0.51-0.72-1.01-2.13-1.72
Non GAAP EPS
-0.49-0.73-1.03-2.13-1.72
 
Statistics

All data in USD

Charts